Meeting
2016 Gastrointestinal Cancers Symposium
Could the PD-1 pathway be a potential target for treating small intestinal adenocarcinoma?
Authors
Chanjuan Shi
Vanderbilt University Medical Center, Nashville, TN
Chanjuan Shi , Ramya Thota , Jordan Berlin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 233)
DOI
10.1200/jco.2016.34.4_suppl.233
Abstract #
233
Poster Bd #
B21
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Immunogenicity of clear cell ovarian cancer: Association with ARID1A loss, microsatellite instability and endometriosis.
First Author: Kyle Strickland
Poster
2016 ASCO Annual Meeting
Objective measurement and significance of PD-L1, B7-H3, B7-H4 and TILs in Small Cell Lung Cancer (SCLC).
First Author: Kurt Alex Schalper
Poster
2016 ASCO Annual Meeting
Analysis of immune infiltrates in a genomically characterized clinical cohort of head and neck squamous cell carcinoma (HNSCC) patients (pts).
First Author: Nicole Grace Chau
Poster
2014 ASCO Annual Meeting
Tumor-infiltrating lymphocytes (TILs) and expression of PD-L1 in melanoma brain metastases (BM).
First Author: Anna Sophie Berghoff